Breaking News

Nordic Nanovector, Isotope Technologies Enter Supply Pact

Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nordic Nanovector ASA has signed a long-term global supply agreement with Isotope Technologies Garching GmbH (ITG) to ensure the supply of high quality, no-carrier-added (n.c.a.) Lutetium-177, a key component of Betalutin (177Lu-lilotomab-satetraxetan) for R&D, clinical and commercial uses. ITM, a biotechnology and developer and producer of radiopharmaceuticals and radionuclides for the targeted treatment of cancers as well as for diagnostics, has been supplying n.c.a. Lutetium-177 (Endol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters